The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients

DecisionDx^®-UM Overview

Genomic testing with DecisionDx-UM enables accurate assessment of metastatic risk.

Clinical Validation

DecisionDx-UM is extensively researched including multiple prospective studies.

Test Process

Learn more about the straightforward ordering process for DecisionDx-UM.

Scientific References

DecisionDx-UM is supported by 19 peer-reviewed publications.

Resources

A broad range of resources are available to support the use of DecisionDx-UM.

Additional Uveal Melanoma Tests

Additional DecisionDx tests designed to improve the treatment and management of uveal melanoma.